Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP122730.RAWlY4vBaSSCh3POwSFnGbIyDK2kv3X_mKXRJn-b61iI0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP122730.RAWlY4vBaSSCh3POwSFnGbIyDK2kv3X_mKXRJn-b61iI0130_assertion type Assertion NP122730.RAWlY4vBaSSCh3POwSFnGbIyDK2kv3X_mKXRJn-b61iI0130_head.
- NP122730.RAWlY4vBaSSCh3POwSFnGbIyDK2kv3X_mKXRJn-b61iI0130_assertion description "[Methylenetetrahydrofolate reductase A1298C and plasminogen activator inhibitor-1 4G variants recurred more frequently in HA patients with a less-severe phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP122730.RAWlY4vBaSSCh3POwSFnGbIyDK2kv3X_mKXRJn-b61iI0130_provenance.
- NP122730.RAWlY4vBaSSCh3POwSFnGbIyDK2kv3X_mKXRJn-b61iI0130_assertion evidence source_evidence_literature NP122730.RAWlY4vBaSSCh3POwSFnGbIyDK2kv3X_mKXRJn-b61iI0130_provenance.
- NP122730.RAWlY4vBaSSCh3POwSFnGbIyDK2kv3X_mKXRJn-b61iI0130_assertion SIO_000772 18459951 NP122730.RAWlY4vBaSSCh3POwSFnGbIyDK2kv3X_mKXRJn-b61iI0130_provenance.
- NP122730.RAWlY4vBaSSCh3POwSFnGbIyDK2kv3X_mKXRJn-b61iI0130_assertion wasDerivedFrom gad-20150221 NP122730.RAWlY4vBaSSCh3POwSFnGbIyDK2kv3X_mKXRJn-b61iI0130_provenance.
- NP122730.RAWlY4vBaSSCh3POwSFnGbIyDK2kv3X_mKXRJn-b61iI0130_assertion wasGeneratedBy ECO_0000203 NP122730.RAWlY4vBaSSCh3POwSFnGbIyDK2kv3X_mKXRJn-b61iI0130_provenance.